Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Exercise/Conversion of 1,250 DNTH shares, $24.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 1,250 | $24.2K |
| Jul 29, 2026 | Oncology Institute, Inc. (TOI) | Grant/Award | 41,165 | n/a |
| May 22, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 6,090 | n/a |
| Nov 24, 2025 | Oncology Institute, Inc. (TOI) | Grant/Award | 67,901 | n/a |
| May 22, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 12,500 | n/a |
| Nov 25, 2024 | Oncology Institute, Inc. (TOI) | Grant/Award | 56,000 | n/a |
| May 28, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 11,000 | n/a |
| Dec 28, 2023 | Oncology Institute, Inc. (TOI) | Grant/Award | 56,000 | n/a |
| Sep 14, 2023 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 6,500 | n/a |
| Mar 22, 2023 | Oncology Institute, Inc. (TOI) | Grant/Award | 26,247 | n/a |